Fannie Mae (OTCBB: FNMA) surged 20% at Monday's close with a volume of 53 million shares traded at Relative Strength Index of 72.14 which is considered overbought at these levels. The stock has recently been on a run piercing through its 20 day moving average of $.39 and 50 day moving average of $.47 with continuous increased activity in volume.
Federal National Mortgage Association (Fannie Mae) is a government-sponsored enterprise (GSE) chartered by the United States Congress to support liquidity and stability in the secondary mortgage market, where mortgage related assets are purchased and sold. The Company's activities include providing market liquidity by securitizing mortgage loans originated by lenders in the primary mortgage market into Fannie Mae mortgage-backed securities (Fannie Mae MBS), and purchasing mortgage loans and mortgage-related securities in the secondary market for its mortgage portfolio.
Juniper Group (OTCBB: JUNP) has also shown increased activity in volume as it rose 51.4 million shares. The stock opened at 0.00050 and closed at 0.00070, a total change of 40% gain. It's RSI level is at 61.34, which is considered an overbought condition. This subpenny is very volatile, but has a healthy volume of liquidity. In any case, be careful trading this stock as technicals can change at any second.
Juniper Group, Inc., is a holding company focused on the wireless infrastructure service industry. The Company conducts its business, through its wholly owned subsidiaries. The wireless infrastructure services operations are conducted through two wholly owned subsidiaries of Juniper Services, Inc. (Services) a wholly owned subsidiary of Juniper Entertainment, Inc.
Sienna Resources Incorporated (OTCBB: AEFI) has exploded 34.83% or $.31 settling at $1.20. The days range has been between $1.00 and $1.24, and it's 52-week range has been from $.23 up to $1.24. Today it was the mark of hitting its 52-week high with a surging volume of 710,457 shares traded which is at least 13 times its average volume of 40,547 shares. The reason for today's large price per share increase was due to the announcement that the company has located 35 mining claims in the Aquarius Mountains mining district in body County Arizona, which was a region noted for uranium in the rare earth metals.
American Energy Fields, Inc., formerly Sienna Resources, Inc., is a development-stage company. The Company is primarily engaged in the acquisition and exploration of properties that may contain uranium mineralization in the United States. The Company has acquired state leases and federal unpatented mining claims in the state of California for the purpose of exploration and development of uranium minerals on a total of approximately 5,500 acres.
Neoprobe Corporation (OTCBB: NEOP) has announced that its common stock has been cleared for a listing on the New York Stock Exchange AMEX. The company's common stock which currently trades on that OTC bulletin board will resume trading on the NYSE AMEX on or about February 10, 2011. In addition the company's stock symbol will change to NEOP from "OTCBB: NEOP". Stock has had a moderate gain of $.10 or 3.37% with a volume of 654.9K and a relative strength Index of 76.32 which is above the overbought level of 70.
Neoprobe Corporation (Neoprobe) is a biomedical company that develops and commercializes oncology products. The Company markets a range of medical devices, its neoprobe gamma detection systems (GDS). In addition to ITS medical device products, it has two radiopharmaceutical products, Lymphoseek and RIGScan CR, in advanced phases of clinical development.
Transfer Technology (OTCBB: TTIN) announced today that its 100% owned subsidiary, Organic Products International, through its marketing partner Phillips Sales and Marketing, has been approved as a vendor and sold their Avenger Bed Bud Killer product to the nation's second largest drug store chain.
Stock has catapulted 40% or 0.003 cents to settle at $0.01 cent. Its average volume normally is at 182,052 shares, but today the volume has exploded 64,122,858 shares, which is almost 40 times its average. The company has a market cap of about 1.18 million shares and the stock range has been up for the past 52 weeks from one cent to almost seven cents.
Neoprobe Corporation (Neoprobe) is a biomedical company that develops and commercializes oncology products. The Company markets a range of medical devices, its neoprobe gamma detection systems (GDS). In addition to ITS medical device products, it has two radiopharmaceutical products, Lymphoseek and RIGScan CR, in advanced phases of clinical development.
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any stocks listed in this stock news report
